Nucleosides and nucleotides. 150. Enzymatic synthesis of 5′-phosphatidyl derivatives of 1-(2-C-cyano-2-deoxy-β-D-Arabino-pentofuranosyl)cytosine (CNDAC) and their notable antitumor effects in mice

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 9, 1996, Pages 1021-1024

  Shuto, Satoshi ^a   Awano, Hirokazu ^a   Shimazaki, Naomi ^b   Hanaoka, Kenji ^b   Matsuda, Akira ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 CYANO 2 DEOXY 5 DISTEAROYLPHOSPHATIDYL BETA D ARABINO PENTOFURANOSYL) CYTOSINE; 1 (2 CYANO 2 DEOXY BETA D ARABINO PENTOFURANONSYL)CYTOSINE; ANTINEOPLASTIC AGENT; CYTARABINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; INTRAPERITONEAL DRUG ADMINISTRATION; MASS SPECTROMETRY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; SARCOMA;

EID: 0029945446     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00162-X     Document Type: Article

References (22)

1. Part 149: Obara, T.; Shuto, S.; Saito, Y.; Snoeck, R.; Andrei, G.; Balzarini, J.; De Clercq, E.; Matsuda, A. J. Med. Chem. Submitted for publication.
2. a) Matsuda, A.; Nakajima, Y.; Azuma, A.; Tanaka, M.; Sasaki, T. J. Med. Chem. 1991, 34, 2917-2919.
3. b) Azuma, A.; Nakajima, Y.; Nishizono, N.; Minakawa, N.; Suzuki, M.; Hanaoka, K.; Kobayashi, T.; Tanaka, M.; Sasaki, T. J. Med. Chem. 1993, 36, 4183-4189.
4. c) Tanaka, M.; Matsuda, A.; Terao, T.; Sasaki., T. Cancer Lett. 1992, 64, 67-74.
5. d) Azuma, A.; Hanaoka, K.; Kurihara, A.; Kobayashi, T.; Miyauchi, S.; Kamo, N.; Tanaka, M.; Sasaki, T.; Matsuda, A. J. Med. Chem. 1995, 38, 3391-3397.
6. e) Matsuda, A.; Azuma, A.; Nucleosides Nucleotides, 1995, 14, 461-471.
7. a) Shuto, S.; Ueda, S.; Imamura, S.; Fukukawa, K.; Ueda, T. Chem. Pharm. Bull. 1988, 36, 5020-5023.
8. b) Shuto, S.; Itoh, H.; Endo, E.; Fukukawa, K.; Tsujino, M.; Matsuda, A.; Ueda, T. Chem. Pharm. Bull. 1987, 35, 3523-3526.
9. c) Turcotte, J. G.; Srivastava, S. P.; Meresak, W. A.; Rizkalla, B. A.; Louzon, F.; Wunz, T. P. Biochim. Biophys. Acta 1980, 619, 604-618.
10. d) Hong, C. I.; An, S.-H.; Buchheit, D. J.; Nechaev, A.; Kirisits, A. J.; West, C. R.; Berdel, W. E. J. Med. Chem. 1986, 29, 2038-2044.
11. e) Herrmann, R.; Berdel, W. E. Cancer Res. 1992, 52, 1865-1867.
12. f) Neumann, J. -M.; Herve, M.; Debouzy, J. -C; Iglesias, G. F.; Gouyette, C.; Dupraz, B.; Huynh-Dinh, T. J. Am. Chem. Soc., 1989, 111, 4270-4377.
13. g) Hosteller, K. Y.; Parker, S.; Sridhar, C. N.; Martin, M. J.; Li. J. -L.; Stuhmiller, L. M. van Wijk, G. M. T.; van den Bosch, H.; Gardner, M. F.; Aldern, K. A.; Richman, D. D. Proc. Natl. Acad. Sci. USA, 1993, 90, 11835-11839.
14. a) Shuto, S.; Ueda, S.; Imamura, S.; Fukukawa, K.; Tsujino, M.; Matsuda, A.; Ueda, T. Tetrahedron Lett. 1987, 28, 199-202.
15. b) Shuto, S.; Itoh, H.; Ueda, S.; Imamura, S.; Fukukawa, K.; Tsujino, M.; Matsuda, A.; Ueda, T. Chem. Pharm. Bull. 1988, 36, 209-217.
16. c) Shuto, S.; Itoh, H.; Obara, T.; Nakagami, K.; Yaso, M.; Yaginuma, S.; Tsujino, M.; Saito, T.; Matsuda, A.; Ueda, T. Nucleosides Nucleotides 1992, 11, 437-446.
17. d) Sakai, A.; Mon, N.; Shuto, S.; Suzuki, T. J. Pharm. Sci. 1993, 82, 575-578.
18. e) Doi, K.; Oku, N.; Toyota, T.; Shuto, S.; Sakai, A.; Itoh, H.; Okada, S. Biol. Pharm. Bull., 1994, 17, 1414-1416.
19. f) Shuto, S.; Itoh, H.; Sakai, A.; Nakagami, K.; Imamura, S.; Matsuda, A. BioMed. Chem. 1995, 3, 235-243.
20. + form) giving 3 as a sodium salt.
21. a) Hermetter, A.; Paltauf, F.; Hauser, H. Chem. Phys. Lipids 1982, 30, 35-45.
22. b) Browning, J.; Seelig, J. Chem. Phys. Lipids 1979, 24, 103-118.